Optical biodetector demonstrates successful anthrax and ricin toxin detection

Stratophase optical microchip detector

Stratophase (Romsey, England) recently wrapped its involvement in the Portable Integrated Battlespace Biological Detection Technology (PIBBDT) project, which involved a consortium of commercial, academic and military specialists in collector technology, biodetection and microfluidics. The project, led by manufacturer Biral and funded by the UK Ministry of Defense, involved building two fully functioning portable prototype systems for detecting biohazards in an atmospheric environment, which were tested in an exposure chamber using model-agents to simulate the relevant biohazards.

The work demonstrated the feasibility of using the complete system to collect biological factors from the atmosphere, concentrate them in a liquid sample, and then detect pre-defined hazardous materials within the sample using Stratophase’s optical microchip detector. The microchip was also tested separately in laboratories at Dstl’s bioagent exposure facility with real targets, including several well-known bio-warfare factors, such as B. anthracis (the causative agent of anthrax) and Ricin toxin. This microchip employs the company's optical technology in combination with immunoassay receptor chemistry to detect biological agents with a high degree of specificity and sensitivity, forming an essential part of the prototype system.

Stratophase's optical microchip technology detects changes in the refractive index of a liquid passing over its surface. When used as a biodetector, the chip is coated with specific antibodies that bind with high specificity and affinity to biological targets. When a given toxin, bacteria or virus is present in the sample, it binds and triggers a positive detection.

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Follow OptoIQ on your iPhone; download the free app here.

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Johnson & Johnson to acquire ophthalmic device maker Abbott Medical Optics for $4.33B

The acquisition will include Abbott's ophthalmic products in cataract surgery, laser refractive surgery, and consumer eye health.

Third FDA-approved study supports additional potential use of laser ablation technology

The FDA has approved an additional Investigational Device Exemption (IDE) to evaluate the NeuroBlate laser ablation system.

Contract to provide U.S. Armed Forces access to laser procedure for gum tissue regeneration

The U.S. Armed Forces will have access to a laser procedure for fully regenerating gum tissues lost to disease.

Avinger signs agreement with HealthTrust for OCT image-guided atherectomy system

HealthTrust will acquire Avinger's Pantheris OCT image-guided atherectomy system that recently received FDA approval.

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS